ArticleCancer management and research2019

Cost-Effectiveness Analysis Of Ceritinib And Alectinib Versus Crizotinib In The Treatment Of Anaplastic Lymphoma Kinase-Positive Advanced Non-Small Cell Lung Cancer.

Maobai Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.